Company intelligence / Profile preview

MedQuimica

Juiz de Fora, Minas Gerais, Brazil

Ownership: Private
Employees: ~500
Development stage: Other

Overview

MedQuímica is a prominent Brazilian pharmaceutical company headquartered in Juiz de Fora, Minas Gerais. Founded in 1975, the company specializes in the development, manufacturing, and commercialization of a wide range of generic, branded generic, and over-the-counter (OTC) medications. In 2015, MedQuímica was acquired by Lupin, a global pharmaceutical leader, which integrated the company into its Latin American operations. The company operates a modern manufacturing facility and maintains a significant presence in the Brazilian retail pharmacy market. Its portfolio spans various therapeutic areas, including analgesics, antibiotics, and cardiovascular health.

Therapeutic areas: ImmunologyCardiovascularNeurologyInfectious DiseasesGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on MedQuimica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedQuimica.

Explore the full profile